Navigation Links
InfoLogix Receives Nasdaq Deficiency Letter
Date:9/21/2009

HATBORO, Pa., Sept. 21 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a deficiency letter, dated September 16, 2009, from the NASDAQ Stock Market stating that based on the closing bid price of the company's listed securities for the last 30 consecutive business days, InfoLogix no longer meets the minimum $1.00 per share requirement for continued listing on The NASDAQ Capital Market under Marketplace Rule 5550(a)(2). Under Marketplace Rule 5810(c)(3)(A), InfoLogix has a grace period of 180 calendar days, or until March 15, 2010, in which to regain compliance with the minimum bid price rule.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090618/NE35135LOGO )

If at any time before March 15, 2010, the bid price of the company's securities closes at $1.00 per share or more for a minimum of 10 consecutive business days, NASDAQ stated that it will notify InfoLogix that it has achieved compliance with the minimum bid price rule and the matter will be closed. If InfoLogix does not regain compliance with the minimum bid price rule before March 15, 2010, NASDAQ stated that it will provide InfoLogix with written notice that its securities are subject to delisting. At that time, InfoLogix may appeal NASDAQ's determination to a NASDAQ Listing Qualifications Panel, which would stay any further delisting action by NASDAQ pending a final decision by the panel. Alternatively, NASDAQ stated that InfoLogix may be eligible for an additional grace period if it meets the initial listing standards, with the exception of bid price, for The NASDAQ Capital Market. NASDAQ further stated that if InfoLogix meets the initial listing criteria, the NASDAQ staff will notify InfoLogix that it has been granted an additional 180 calendar day compliance period.

InfoLogix will attempt to regain compliance with NASDAQ's minimum bid price rule, but there can be no assurance that it will be able to do so.

About InfoLogix, Inc.

InfoLogix is a leading provider of enterprise mobility solutions for the healthcare and commercial industries. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, MultiCare Health System and Stanford School of Medicine. InfoLogix is a publicly-traded company. For more information visit www.infologix.com.

Safe Harbor

InfoLogix makes forward-looking statements, including those relating to plans for regaining compliance with the NASDAQ rules, in this press release which represent our expectations or beliefs about future events and financial performance. Forward-looking statements are identifiable by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Forward-looking statements are subject to known and unknown risks and uncertainties, including the risks described in our Annual Report on Form 10-K for the period ended December 31, 2008, our Quarterly Report on Form 10-Q for the period ended June 30, 2009 and other filings we make with the Securities and Exchange Commission. In addition, actual results could differ materially from those suggested by the forward-looking statements, and therefore you should not place undue reliance on the forward-looking statements. We do not make any commitment to revise or update any forward-looking statements to reflect events or circumstances occurring or existing after the date of any forward-looking statement is made.

    Contact:
    John A. Roberts
    Chief Financial Officer
    215-604-0691 x1102


'/>"/>
SOURCE InfoLogix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. InfoLogix Announces Approval for NASDAQ Listing
2. InfoLogix Acquires Healthcare Informatics Associates Inc. (HIA); Adds Premier Healthcare Consulting Firm and Systems Integrator
3. InfoLogix Signs Largest International Deal to Date with Healthcare Solutions Agreement in United Arab Emirates
4. InfoLogix to Report Third Quarter and Nine Month Financial Results on November 8, 2007
5. InfoLogix Featured in FOX Business News Interview on Reducing Healthcare Medication Errors - Video Available Online
6. InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL
7. Dollar Thrifty Automotive Group Expands Mobile Managed Services Contract with InfoLogix
8. InfoLogix to Report First Quarter Results on April 30, 2008
9. InfoLogix Announces First Quarter 2008 Financial Results
10. InfoLogix to Report First Quarter Results on April 30, 2008 - Conference Call Information
11. InfoLogix Completes $25 Million Senior Debt Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... , ... April 26, 2017 , ... RawTrition now brings ... way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients to ... cellular level because the body recognizes its raw form (unlike the synthetically made options ...
(Date:4/25/2017)... ... ... Bellus Medical, a leader in medical aesthetics, recently acquired ... photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated to ... minimize the appearance of pores – all with minimal downtime and results that ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump ... preparing for how his administration could impact the employee benefits industry. James Slotnick, ... are most likely to make it through Congress. His discussion will focus on ...
(Date:4/25/2017)... ... 25, 2017 , ... As pharmaceutical companies are held to ... process innovation in drug formulation and manufacturing. CoreRx offers its clients more ... in support of their development and manufacturing goals. , The company was ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... of predictive analytics to its patient care management module. Using this new feature, ... a patient has been initiated on continuous positive airway pressure (CPAP), oral, or ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... April 24, 2017 Solentim, the developer ... the addition of a major new product line ... Seeding,). The VIPS has been developed for automatically ... microplates as part of the process to generate ... simple and more reliable solution when compared to ...
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... 2017  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... that it will be participating in the Deutsche Bank ... Hotel in Boston, Massachusetts on ... 11:20 a.m. Eastern Time. A live webcast ... Investor Relations website at http://investor.zimmerbiomet.com .  The webcast ...
Breaking Medicine Technology: